Reuters

New oral testosterone undecanoate formulation restores normal testosterone levels

NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
Healio

Oral testosterone therapy improves sexual activity for men

Please provide your email address to receive an email when new articles are posted on . Oral testosterone undecanoate increased serum testosterone levels to 450 ng/dL for 92% of men. A clinically ...
Morningstar

ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option

EXTON, Pa., Jan. 21, 2026 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the commercial availability of its oral testosterone, a ...

6 everyday things that may be messing with your testosterone

In a T-rrible slump? As the primary male sex hormone, testosterone is essential for maintaining libido, erectile function, ...
Nasdaq

Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to ...
Hosted on MSN

No shots, new choice: Pa. firm launches needle-free oral testosterone

EXTON, PA — ProRx Pharma says it has begun commercial distribution of a needle-free oral testosterone therapy, positioning the product as a first-of-its-kind alternative designed to deliver the ...
Business Insider

Lipocine Validates “No Titration” Dosing Regimen With Positive Topline Efficacy Results for LPCN 1021, Oral Testosterone Candidate

LPCN 1021 achieved primary endpoints confirming the efficacy of twice daily oral administration LPCN 1021 generally met the pre-specified per dose secondary endpoints for twice daily oral ...
KRON4 News

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy ...

RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™, one of the largest digital health platforms for men, to make KYZATREX ...
Medscape

FDA Panel Rejects New Oral Testosterone Replacement Drug

A combined US Food and Drug Administration (FDA) advisory committee has voted against recommending approval of oral testosterone undecanoate (TU) gel capsules as testosterone-replacement therapy (TRT) ...
KTLA

Marius Pharmaceuticals Announces Pilot Study Exploring the Effect of Its Oral Testosterone Therapy, KYZATREX® (CIII testosterone undecanoate capsules), on Male Fertility

RALEIGH, N.C., Jan. 9, 2024 /PRNewswire/ -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced it has initiated a ...
Business Insider

Marius Pharmaceuticals Partners with Major Academic Medical Center on Education and Research Efforts for Oral Testosterone

RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke ...